3M vs Coca-Cola Europacific Partners
Global industrial conglomerate spanning safety consumer and healthcare products vs Major Coca-Cola bottler across Europe and Asia-Pacific. Which is the better buy for your portfolio in June 2026? Plain-English answer below.
3M is a diversified industrials conglomerate managing a massive litigation overhang from its earplugs and PFAS liabilities while trying to reinvigorate organic growth across its materials and electronics businesses, while Coca-Cola Europacific Partners bottles and distributes Coke's brands across Western Europe, Australia, and Indonesia with disciplined execution and a clear volume growth story. Both companies have long histories of returning capital to shareholders through dividends and buybacks and serve as anchor holdings for income-focused portfolios. The 3M vs Coca-Cola Europacific Partners comparison contrasts an industrial compounder navigating legal uncertainty with a consumer staples bottler running a cleaner playbook.
3M is a diversified industrials conglomerate managing a massive litigation overhang from its earplugs and PFAS liabilities while trying to reinvigorate organic growth across its materials and electron...
Why It’s Moving
3M’s outlook stays anchored by mixed analyst views as investors wait for a fresh catalyst.
- Wall Street’s 12-month price targets cluster in the mid-to-high $160s, signaling that analysts see upside but are still cautious on the pace of 3M’s turnaround.
- Consensus ratings are split between Buy and Hold, which suggests the market sees improvement potential but wants more evidence before re-rating the stock higher.
- With no major news in the past 7 days, 3M is likely trading off sector-wide industrial sentiment, including concerns about demand durability and the company’s ability to convert operational changes into stronger earnings power.
CCEP slips as analysts turn more cautious after a strong run and softer near-term visibility.
- Morgan Stanley cut CCEP from Overweight to Equal-weight, signaling that recent gains may have already captured much of the good news.
- Analysts pointed to a more balanced risk-reward setup, suggesting the stock’s valuation has caught up with its recent performance.
- Short-term revenue visibility has softened, which can weigh on sentiment even when the underlying business remains stable.
3M’s outlook stays anchored by mixed analyst views as investors wait for a fresh catalyst.
- Wall Street’s 12-month price targets cluster in the mid-to-high $160s, signaling that analysts see upside but are still cautious on the pace of 3M’s turnaround.
- Consensus ratings are split between Buy and Hold, which suggests the market sees improvement potential but wants more evidence before re-rating the stock higher.
- With no major news in the past 7 days, 3M is likely trading off sector-wide industrial sentiment, including concerns about demand durability and the company’s ability to convert operational changes into stronger earnings power.
CCEP slips as analysts turn more cautious after a strong run and softer near-term visibility.
- Morgan Stanley cut CCEP from Overweight to Equal-weight, signaling that recent gains may have already captured much of the good news.
- Analysts pointed to a more balanced risk-reward setup, suggesting the stock’s valuation has caught up with its recent performance.
- Short-term revenue visibility has softened, which can weigh on sentiment even when the underlying business remains stable.
Investment Analysis
3M
MMM
Pros
- 3M delivered positive organic sales growth of 1.5% year-over-year in recent quarters, showing improving top-line momentum.
- Adjusted operating margin increased by 290 basis points year-over-year, indicating enhanced profitability and operational efficiency.
- The company raised its full-year 2025 adjusted EPS guidance twice, projecting adjusted profits between $7.95 and $8.05 per share.
Considerations
- GAAP EPS declined 38% year-over-year, reflecting continued challenges under generally accepted accounting principles.
- Operating cash flow was negative $1 billion recently, raising concerns about cash generation despite adjusted free cash flow of $1.3 billion.
- Stock price forecasts suggest a potential decline of up to 7-9% by the end of 2025, indicating market skepticism despite recent earnings beats.
Pros
- Coca-Cola Europacific Partners is the second-largest bottling partner in the Coca-Cola system, covering developed Europe and Asia-Pacific.
- In 2024, it sold approximately 3.9 billion unit cases, representing about 9% of Coca-Cola’s global system volume, illustrating significant market presence.
- The company maintains a solid dividend yield around 2.36%, offering steady income generation potential for investors.
Considerations
- The Coca-Cola Company exerts strong bargaining power over pricing and brand control, limiting CCEP’s pricing flexibility and margins.
- CCEP’s debt-to-equity ratio is relatively high at about 133%, raising leverage and financial risk concerns.
- Operating in mature developed markets, growth prospects may be constrained compared to emerging market competitors.
3M (MMM) Next Earnings Date
The next earnings date for 3M (MMM) is estimated for July 17, 2026, based on its historical reporting pattern. The upcoming report is expected to cover Q2 2026. This date has not yet been formally confirmed by the company.
Coca-Cola Europacific Partners (CCEP) Next Earnings Date
The next earnings date for CCEP is August 4, 2026. Based on the company’s reporting cadence, that release should cover second-quarter 2026 results. Some calendars show a broader window around early August, but August 4, 2026 is the clearest current estimate.
3M (MMM) Next Earnings Date
The next earnings date for 3M (MMM) is estimated for July 17, 2026, based on its historical reporting pattern. The upcoming report is expected to cover Q2 2026. This date has not yet been formally confirmed by the company.
Coca-Cola Europacific Partners (CCEP) Next Earnings Date
The next earnings date for CCEP is August 4, 2026. Based on the company’s reporting cadence, that release should cover second-quarter 2026 results. Some calendars show a broader window around early August, but August 4, 2026 is the clearest current estimate.
Buy MMM or CCEP in Nemo
Zero Commission
Trade stocks, ETFs, and more with zero commission. Keep more of your returns.
Trusted & Regulated
Part of Exinity Group 2015, serving over a million customers globally.
6% Interest on Cash
Earn 6% AER on uninvested cash with daily interest payments.
